Published Date – 25 November 2024
Women As One, in partnership with the Global CVCT Forum, is delighted to announce the Escalator Awards Research Scholars for 2024. Now in its second year, this prestigious award aims to support and promote high-potential women physicians with growing interest and experience in clinical trials. The program, previously known as the CLIMB Research Scholars Program in 2023, continues to build on its mission to enhance the visibility of women in clinical trial leadership and create professional connections that foster future success.
In September, a call for nominations was distributed to a select group of leaders in cardiology, including current CVCT faculty, CLIMB faculty, and Escalator Awards reviewers. This resulted in 20 nominations of rising women trialists from seven countries. In early November, a review committee of six world-leading physicians convened to evaluate the nominations and select the winners. This esteemed committee included faculty from both Women As One programs and CVCT.
The program is designed to support the overarching mission of Women As One: creating unique professional opportunities for women physicians, focusing on developing more clinical trial leaders. Research consistently shows that diversity in clinical trial leadership enhances the diversity of patient recruitment, leading to more relevant and comprehensive scientific findings.
We are thrilled to partner with Women As One for the second year for these important awards to help get more women involved in clinical trial leadership. We know this will help ensure a greater diversity of patients participating in clinical trials, improving patient outcomes.
Faiez Zannad, CVCT Founder and Chair
Assistant Professor of Medicine and non-invasive cardiologist at Mayo Clinic in Florida, USA. Her research focuses on heart disease in women and using novel digital technologies and artificial intelligence to improve cardiovascular care and enhance health equity.
Advanced Heart Failure and Transplant Cardiologist and Assistant Professor of Medicine at the University of Colorado School of Medicine, USA. Her clinical and research work centers on cardiometabolic disease and heart failure, particularly the intersection of obesity and heart failure, clinical biomarkers, and clinical trial design and execution.
Assistant Professor of Medicine at the University of Pittsburgh Medical Center, USA. She focuses on cardiac issues in pregnancy and early detection of cardiovascular disease among young populations, with a commitment to increasing the enrollment of reproductive-aged individuals in clinical trials.
Clinical Lecturer in Renal Medicine at the University of Glasgow, UK. She holds a Postgraduate Certificate in statistics and epidemiology. She has recently submitted her PhD thesis on the effects of empagliflozin on fluid overload, weight and blood pressure in chronic kidney disease.
Cardiologist at Brigham and Women’s Hospital, USA. Her clinical and research interests lie in cardio-obstetrics and cardiovascular women’s health, aiming to address sex-specific and racial/ethnic disparities in cardiovascular disease.
Clinician-scientist in nephrology and internal medicine at University Hospital Würzburg, Germany. Her work is dedicated to improving cardiovascular and renal outcomes for patients with kidney disease through rigorous randomized controlled trials and real-world data analysis.
Advanced heart failure and genetic cardiologist and physician-scientist at the University of Pennsylvania, USA. Her research focuses on improving care for individuals with genetic cardiomyopathies, and she actively participates in multiple clinical trials of novel therapies.
We’re thankful once again to CVCT for our ongoing partnership in support of women in clinical trials. Thanks to their commitment, we can provide more opportunities to international women physicians at the world-leading CVCT Forum. We would also like to thank program sponsors Abbott and Novo Nordisk for their dedication to uplifting talented women in our community.
Karoline Bowman, Head of Program Operations, Women As One
The awardees will attend the Global CVCT Forum from December 9-11, 2024, and feature prominently in the faculty with their involvement tailored to their clinical specialties. Additionally, they will participate in a leadership lunch with key faculty from CVCT, Women As One, and industry leaders. This lunch provides a valuable opportunity for the awardees to discuss their paths to clinical trial leadership in an informal setting and learn from trailblazers in the field.
We are also excited to highlight a joint session at the CVCT Forum titled “Women In Trials: Yes We Can!” which will take place on Monday morning, December 9th. Notably, 2023 Research Scholars award winner Dr. Erin Bohula will present during this session, sharing her insights and experiences.
Women As One and CVCT Forum remain committed to fostering diversity in clinical trial leadership and providing invaluable opportunities for women in cardiology. We want to thank Abbott and Novo Nordisk for their generous sponsorship of these awards.
The Talent Directory is a global professional community explicitly tailored for women cardiologists across diverse medical specialties.
Join us to embark on a journey of professional growth, collaboration, and empowerment. Together, let’s redefine the future of medicine.